Stéphane Burgatt, edited by Solène Delinger
They are classified at risk and their immune system responds poorly, or not to vaccines against Covid … Immunocompromised people today feel trapped in the face of the epidemic resumption. The spread of Omicron is a vector of stress for these patients, forced into self-containment. Six associations recently questioned Emmanuel Macron on this subject.
Their body does not react or reacts little to the vaccine against the Covid-19. The immunocompromised are more exposed to severe forms of the disease and occupy up to a third of intensive care beds in hospitals. The others impose drastic restrictions on themselves so as not to contract the virus. Reporting.
Decisions with serious consequences
Delphine Blanchard received four injections of the vaccine, to no avail. Kidney transplant, she has practically cut herself off from all outside contact since the release of Omicron. A particularly anxiety-provoking situation. “Me, I’m very scared. I feel in a state of imminent death”, she confides in the microphone of Europe 1. “I do not go out any more. It is my husband who does all the shopping. Do not go out, except to go on dialysis “.
But these sessions in the hospital can again put him at risk. “So much so that I ask myself the question of having dialysis only once a week”, explains Delphine. “These are decisions that can have very serious consequences, but I prefer to limit dialysis, even if it means putting myself in danger in the medium term”.
Health emergency
In France, 300,000 people suffer from immunodeficiency. There is an emergency according to Étienne Klein, director of the Ellye association, Ensemble leukemia lymphoma hope. “The emergency is becoming more and more precise. As these people are unresponsive or poorly respond to vaccination, their immune defenses do not allow them to fight effectively against the virus. And they find themselves quite easily in intensive care units, in intensive care “.
And several of these associations are thus campaigning for free FFP2 masks and simplified access to preventive treatments for immunocompromised people, while hoping that the development of vaccination will continue and accelerate in France.